Search

Search Constraints

You searched for: Author/Creator Pfeifer, Andrea

Search Results

1. Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression. Issue 1 (December 2018)

2. P4–316: Visualization of beta‐amyloid plaque reduction by small‐molecule beta‐amyloid oligomer aggregation inhibitors in hAPPSL transgenic mice. (1st July 2013)

3. [IC‐01–05]: FIRST‐IN‐HUMAN PET STUDIES WITH THE NEXT GENERATION TAU AGENT 18‐F PI‐2620 IN ALZHEIMER's DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY, AND CONTROLS. (1st July 2017)

4. DT‐02‐06: NOVEL ALPHA‐SYNUCLEIN POSITRON EMISSION TOMOGRAPHY (PET) TRACERS FOR THE DIAGNOSIS OF PARKINSON'S DISEASE. (1st July 2006)

5. [IC‐P‐192]: PRECLINICAL CHARACTERIZATION OF PI‐2620, A NOVEL TAU PET TRACER FOR DETECTION OF TAU IN AD AND OTHER TAUOPATHIES. (1st July 2017)

6. O2–06–04: A liposomal anti‐phospho‐tau vaccine demonstrates higher immunogenicity and specificity than a classical peptide vaccine approach. (1st July 2013)

7. [P4–099]: CHANGES IN TAU PROTEIN LANDSCAPE DURING ALZHEIMER's DISEASE PROGRESSION. (1st July 2017)

8. [P3–067]: DEVELOPMENT OF HIGHLY SENSITIVE MSD ASSAYS FOR THE DETECTION OF ANTI‐AMYLOID β MONOMER‐ AND OLIGOMER‐SPECIFIC ANTIBODIES IN HUMAN SERUM. (1st July 2017)

9. P2‐054: Tau antibodies lacking effector function minimize inflammatory responses while effectively blocking spread of tau pathology. (1st July 2015)

10. O2‐13‐03: Efficacy of ACI‐35, A Liposomal Anti‐Phospho Tau Vaccine in Two Different Mouse Models of Alzheimer's Disease. (1st July 2016)